VIEMED HEALTHCARE, INC. Selling, General and Administrative Expense
VIEMED HEALTHCARE, INC. (VMD) reported Selling, General and Administrative Expense of $37.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $37.13M, a 28.92% increase year-over-year.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $34.79M, a 22.40% increase year-over-year.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $32.22M, a 14.21% increase year-over-year.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $31.92M, a 19.68% increase year-over-year.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for fiscal 2025 was $121.37M, a 14.28% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for fiscal 2024 was $106.20M, a 20.84% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for fiscal 2023 was $87.88M, a 28.94% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. selling, general and administrative expense for fiscal 2022 was $68.16M, a 24.17% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $37.13M 10-Q · filed 2026-08-03 | $71.92M 10-Q · filed 2026-08-03 | $104.14M derived: sum of 3 quarters · filed 2026-08-03 | $136.06M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2026-03-31 | $34.79M 10-Q · filed 2026-05-05 | $67.01M derived: sum of 2 quarters · filed 2026-05-05 | $98.93M derived: sum of 3 quarters · filed 2026-05-05 | $127.73M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-12-31 | $32.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $64.14M derived: sum of 2 quarters · filed 2026-03-04 | $92.94M derived: sum of 3 quarters · filed 2026-08-03 | $121.37M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $31.92M 10-Q · filed 2025-11-05 | $60.72M derived: sum of 2 quarters · filed 2026-08-03 | $89.15M 10-Q · filed 2025-11-05 | $117.36M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-06-30 | $28.80M 10-Q · filed 2026-08-03 | $57.23M 10-Q · filed 2026-08-03 | $85.44M derived: sum of 3 quarters · filed 2026-08-03 | $112.11M derived: sum of 4 quarters · filed 2026-08-03 | |||
| 2025-03-31 | $28.43M 10-Q · filed 2026-05-05 | $56.64M derived: sum of 2 quarters · filed 2026-05-05 | $83.31M derived: sum of 3 quarters · filed 2026-05-05 | $109.81M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $28.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $54.88M derived: sum of 2 quarters · filed 2026-03-04 | $81.39M derived: sum of 3 quarters · filed 2026-03-04 | $106.20M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $26.67M 10-Q · filed 2025-11-05 | $53.17M derived: sum of 2 quarters · filed 2025-11-05 | $77.99M 10-Q · filed 2025-11-05 | $101.89M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-06-30 | $26.50M 10-Q · filed 2025-08-06 | $51.32M 10-Q · filed 2025-08-06 | $75.22M derived: sum of 3 quarters · filed 2026-03-04 | $98.88M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-03-31 | $24.81M 10-Q · filed 2025-05-07 | $48.72M derived: sum of 2 quarters · filed 2026-03-04 | $72.37M derived: sum of 3 quarters · filed 2026-03-04 | $92.94M derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2023-12-31 | $23.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $47.56M derived: sum of 2 quarters · filed 2026-03-04 | $68.12M derived: sum of 3 quarters · filed 2026-03-04 | $87.88M 10-K · filed 2026-03-04 | |||
| 2023-09-30 | $23.65M 10-Q · filed 2024-11-06 | $44.22M derived: sum of 2 quarters · filed 2024-11-06 | $63.98M 10-Q · filed 2024-11-06 | $81.15M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2023-06-30 | $20.56M 10-Q · filed 2024-08-07 | $40.33M 10-Q · filed 2024-08-07 | $57.50M derived: sum of 3 quarters · filed 2025-03-10 | $75.17M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2023-03-31 | $19.76M 10-Q · filed 2024-05-06 | $36.93M derived: sum of 2 quarters · filed 2025-03-10 | $54.61M derived: sum of 3 quarters · filed 2025-03-10 | $72.15M derived: sum of 4 quarters · filed 2025-03-10 | |||
| 2022-12-31 | $17.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $34.85M derived: sum of 2 quarters · filed 2025-03-10 | $52.38M derived: sum of 3 quarters · filed 2025-03-10 | $68.16M 10-K · filed 2025-03-10 | |||
| 2022-09-30 | $17.68M 10-Q · filed 2023-11-01 | $35.21M derived: sum of 2 quarters · filed 2023-11-01 | $50.99M 10-Q · filed 2023-11-01 | $65.23M derived: sum of 4 quarters · filed 2023-11-01 | |||
| 2022-06-30 | $17.54M 10-Q · filed 2023-08-09 | $33.31M 10-Q · filed 2023-08-09 | $47.55M derived: sum of 3 quarters · filed 2023-08-09 | $60.81M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $15.78M 10-Q · filed 2023-05-08 | $30.02M derived: sum of 2 quarters · filed 2023-05-08 | $43.28M derived: sum of 3 quarters · filed 2023-05-08 | $56.16M derived: sum of 4 quarters · filed 2023-05-08 | |||
| 2021-12-31 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $27.50M derived: sum of 2 quarters · filed 2023-03-02 | $40.38M derived: sum of 3 quarters · filed 2023-03-02 | $54.89M 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $13.26M 10-Q · filed 2022-11-01 | $26.14M derived: sum of 2 quarters · filed 2022-11-01 | $40.65M 10-Q · filed 2022-11-01 | $52.93M derived: sum of 4 quarters · filed 2022-11-01 | |||
| 2021-06-30 | $12.88M 10-Q · filed 2022-08-02 | $27.39M 10-Q · filed 2022-08-02 | $39.67M derived: sum of 3 quarters · filed 2022-08-02 | $53.22M derived: sum of 4 quarters · filed 2022-08-02 | |||
| 2021-03-31 | $14.51M 10-Q · filed 2022-05-03 | $26.78M derived: sum of 2 quarters · filed 2022-05-03 | $40.33M derived: sum of 3 quarters · filed 2022-05-03 | $56.76M derived: sum of 4 quarters · filed 2022-05-03 | |||
| 2020-12-31 | $12.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $25.82M derived: sum of 2 quarters · filed 2022-03-07 | $42.25M derived: sum of 3 quarters · filed 2022-03-07 | $52.83M 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $13.55M 10-Q · filed 2021-11-02 | $29.98M derived: sum of 2 quarters · filed 2021-11-02 | $40.55M 10-Q · filed 2021-11-02 | $50.73M derived: sum of 4 quarters · filed 2021-11-02 | |||
| 2020-06-30 | $16.43M 10-Q · filed 2021-08-03 | $27.00M 10-Q · filed 2021-08-03 | $37.18M derived: sum of 3 quarters · filed 2021-08-03 | $47.41M derived: sum of 4 quarters · filed 2021-08-03 | |||
| 2020-03-31 | $10.58M 10-Q · filed 2021-05-03 | $20.75M derived: sum of 2 quarters · filed 2021-05-03 | $30.98M derived: sum of 3 quarters · filed 2021-05-03 | $42.50M derived: sum of 4 quarters · filed 2021-05-03 | |||
| 2019-12-31 | $10.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $20.41M derived: sum of 2 quarters · filed 2021-03-03 | $31.92M derived: sum of 3 quarters · filed 2021-03-03 | $41.38M 10-K · filed 2021-03-03 | |||
| 2019-09-30 | $10.23M 10-Q · filed 2020-11-04 | $13.28M 10-Q · filed 2019-11-05 | $21.75M derived: sum of 2 quarters · filed 2020-11-04 | $31.21M 10-Q · filed 2020-11-04 | $38.12M 10-Q · filed 2019-11-05 | $40.90M derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-06-30 | $11.52M 10-Q · filed 2020-08-04 | $13.24M 10-Q · filed 2019-08-09 | $20.98M 10-Q · filed 2020-08-04 | $24.84M 10-Q · filed 2019-08-09 | $30.67M derived: sum of 3 quarters · filed 2020-08-04 | $40.13M derived: sum of 4 quarters · filed 2020-08-04 | |
| 2019-03-31 | $9.46M 10-Q · filed 2020-05-05 | $19.16M derived: sum of 2 quarters · filed 2020-05-05 | $28.62M derived: sum of 3 quarters · filed 2020-05-05 | $36.51M derived: sum of 4 quarters · filed 2020-05-05 | |||
| 2018-12-31 | $9.70M 10-K · filed 2020-03-04 | $19.16M derived: sum of 2 quarters · filed 2020-03-04 | $27.05M derived: sum of 3 quarters · filed 2020-03-04 | $34.30M 10-K · filed 2020-03-04 | |||
| 2018-09-30 | $9.46M 10-K · filed 2020-03-04 | $9.49M 10-Q · filed 2019-11-05 | $17.35M derived: sum of 2 quarters · filed 2020-03-04 | $24.70M 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | $7.89M 10-K · filed 2020-03-04 | $7.92M 10-Q · filed 2019-08-09 | $15.21M 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | $7.26M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |